Glenmark Pharma reports consolidated revenue growth of 6 3 per cent and adjusted EBITDA growth of 8 3 per cent YoY for Q2 FY 2023-24
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Glenmark Pharma receives ANDA approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2 5 mg, 5 mg, and 10 mg
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi in Europe and South Africa
theprint.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theprint.in Daily Mail and Mail on Sunday newspapers.